MYK-224
Showing 1 - 25 of 72
Healthy Volunteers Trial in Anaheim (MYK-224, Placebo)
Completed
- Healthy Volunteers
- MYK-224
- Placebo
-
Anaheim, CaliforniaLocal Institution - 0001
Jan 12, 2023
Cardiomyopathy, Hypertrophic Trial in Bologna, Alicante/alacant (MYK-224)
Not yet recruiting
- Cardiomyopathy, Hypertrophic
- MYK-224
-
Bologna, BO, Italy
- +1 more
Sep 23, 2022
Healthy Participants Trial in Dallas (MYK-224, Itraconazole, Verapamil)
Recruiting
- Healthy Participants
- MYK-224
- +2 more
-
Dallas, TexasLabcorp CRU
Jun 9, 2022
Healthy Volunteers Trial (MYK-224)
Not yet recruiting
- Healthy Volunteers
- MYK-224
- (no location specified)
Jan 6, 2023
Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy, Non-obstructive Hypertrophic Cardiomyopathy Trial in
Active, not recruiting
- Hypertrophic Cardiomyopathy
- +2 more
-
Scottsdale, Arizona
- +68 more
Sep 20, 2022
Hypertrophic Cardiomyopathy Trial in United States (mavacamten)
Active, not recruiting
- Hypertrophic Cardiomyopathy
-
Scottsdale, Arizona
- +3 more
Jun 10, 2022
Alzheimer, Dementia Trial in San Francisco (Moving Together)
Active, not recruiting
- Alzheimer Disease
- Dementia
- Moving Together
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 1, 2023
Hepatocellular Carcinoma Trial (Pembrolizumab)
Active, not recruiting
- Hepatocellular Carcinoma
- Pembrolizumab
- (no location specified)
Dec 15, 2022
Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)
Not yet recruiting
- Primary Membranous Nephropathy
- Obinutuzumab
- Oral prednisolone and cyclophosphamide
-
Garran, Australian Capital Territory, Australia
- +12 more
Nov 1, 2023
CCH With Two Different Injection Techniques in Cellulite With
Enrolling by invitation
- Cellulite
- +2 more
-
Coral Gables, Florida
- +2 more
Feb 28, 2022
Aging, Medication Adherence, Hypertension Trial in Tucson, Champaign (Blood Pressure Technology System M, Blood Pressure
Recruiting
- Aging
- +2 more
- Blood Pressure Technology System M
- Blood Pressure Technology System E
-
Tucson, Arizona
- +1 more
Jan 26, 2023
Cardiomyopathy, Hypertrophic Obstructive, Left Ventricular Outflow Tract Obstruction Trial in United States (MYK-461)
Completed
- Cardiomyopathy, Hypertrophic Obstructive
- Left Ventricular Outflow Tract Obstruction
-
Scottsdale, Arizona
- +6 more
Jun 3, 2021
Obstructive Sleep Apnea Trial in Assiut (adenotonsillectomy, Lifestyle intervention)
Completed
- Obstructive Sleep Apnea
- adenotonsillectomy
- Lifestyle intervention
-
Assiut, EgyptAl-Azhar University
Jun 13, 2022
Obstructive Hypertrophic Cardiomyopathy Trial in Worldwide (mavacamten, Placebo)
Completed
- Obstructive Hypertrophic Cardiomyopathy
- mavacamten
- Placebo
-
Scottsdale, Arizona
- +70 more
Sep 7, 2021
Cannabis Use Disorder, Mild, Cannabis Use Disorder, Moderate, Cannabis Use Disorder, Severe Trial in Charleston (Cognitive
Recruiting
- Cannabis Use Disorder, Mild
- +2 more
- Cognitive Behavioral Therapy (CBT4CBT)
-
Charleston, South CarolinaMedical University of South Carolina
Nov 17, 2021
Dilated Cardiomyopathy, Heart Failure With Reduced Ejection Fraction Trial in Worldwide (MYK-491, Placebo)
Completed
- Dilated Cardiomyopathy
- Heart Failure With Reduced Ejection Fraction
- MYK-491
- Placebo
-
Jacksonville, Florida
- +16 more
Nov 2, 2020
Atopic Dermatitis, Type 1 Hypersensitivity Trial in Australia, Puerto Rico, United States (STMC-103H, Placebo)
Recruiting
- Atopic Dermatitis
- Type 1 Hypersensitivity
- STMC-103H
- Placebo
-
Tucson, Arizona
- +25 more
Dec 1, 2022
Active Peripheral Spondyloarthritis (pSpA) Trial (Secukinumab, Placebo)
Not yet recruiting
- Active Peripheral Spondyloarthritis (pSpA)
- Secukinumab
- Placebo
- (no location specified)
Mar 22, 2022
Rheumatoid Arthritis Trial (MBS2320 5 mg, MBS2320 20 mg, MBS2320 40 mg)
Not yet recruiting
- Rheumatoid Arthritis
- MBS2320 5 mg
- +3 more
- (no location specified)
Jul 12, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022